Ion mobility mass spectrometry with molecular modelling to reveal bioactive isomer conformations and underlying relationship with isomerization
Ion mobility mass spectrometry with molecular modelling to reveal bioactive isomer conformations and underlying relationship with isomerization
复制标题
离子淌度质谱与分子建模揭示生物活性异构体构象以及与异构化的潜在关系
DOI:
10.1002/rcm.8271
复制
发表时间:
2018
影响因子:
2
通讯作者:
Feng Yulin
中科院分区:
文献类型:
--
作者:
Ouyang Hui;Bo Tao;Zhang Zhengxiang;Guo Xinqiu;He Mingzhen;Li Junmao;Yang Shilin;Ma Xin;Feng Yulin
RationaleIn medicine and drug development, molecular modelling is an important tool. It is attractive to develop a platform connecting the theoretical structural modelling and the results from experimental measurement. In addition, the separation and structural analysis of bioactive constituent isomers are still challenging tasks.MethodsDrift tube ion mobility (IM) mass spectrometry (MS) provides the experimental collision cross section (CCS) which contains the structural information. The experimental CCS can be compared with the calculated CCS of the molecular modelling structures. This technique is especially useful for bioactive constituents in herbal medicine because active isomers with the same chemical formula are common in these samples. IM helps separate and identify these isomers and reveals details about their structures and conformations.ResultsTwo model bioactive constituents, caffeoylquinic acids (CQAs) and dicaffeoylquinic acids (di‐CQAs), were selected to systematically investigate the influence of solution, ion source conditions and ion heating on the isomer CCS distributions. By comparing the calculated CCS with the experimental value, we identified the favorable conformations of CQAs. The most compact conformation of a CQA was less likely to isomerize than the more extended conformation. It was found that the isomerization tendency was in accord with the conformation favorability.ConclusionsThis study offers an effective approach to predict and demystify the conformation and isomerization of the active constituents in herbal medicines.